Clinical Trial Update: 18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on 18F-fluorodeoxyglucose positron emission tomography in oncology and neurology; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: University of Manitoba | Conditions: Tumors | Phase 3 | Status: UNKNOWN